溶解性 | 25°C: DMSO |
存贮条件 | 储存温度-20°C |
生化机理 | Description:IC50 Value: 6nM (hFFA1) [1]TUG-770 is a highly potent free fatty acid receptor 1 (FFA1/GPR40) agonist for treatment of type 2 diabetes.in vitro: TUG-770 (Compound 22) displayed excellent physicochemical and in vitro ADME properties, with good aqueous solubility, good chemical stability, low lipophilicity, and decreased plasma protein binding (PPB). TUG-770 furthermore showed excellent stability toward human liver microsomes (HLM), no inhibition of selected CYP-enzymes implicated in drug-drug interactions, no P-glycoprotein (P-gp) inhibition, and good permeability in the Caco-2 cell assay [1].in vivo: Examination of TUG-770 in an acute intraperitoneal glucose tolerance test (IPGTT) in normal mice revealed a good dose dependent response with maximal reduction in glucose level reached at 50 mg/kg. The effect of TUG-770 was fully sustained after 29 days of daily oral treatment. Additional evaluation of TUG-770 in rats confirmed a significant glucose lowering effect for the high doses already after 10 min and for all doses after 30 min [1].Clinical trial: N/A |
TUG-770
TUG-770 (订货以英文为准)
编号:T126560
CAS号:1402601-82-4
分子式:C19H14FNO2
分子量:307.32
产品名称 | TUG-770 |
中文名称 | TUG-770 |
CAS号 | 1402601-82-4 |
分子式(M.F.) | C19H14FNO2 |
分子量(M.W.) | 307.32 |
储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品